Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (319K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Matsukage, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Matsukage, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press 3847-3854

Distinct roles of E2F recognition sites as positive or negative elements in regulation of the DNA polymerase [alpha] 180 kDa catalytic subunit gene promoter during Drosophila development

Distinct roles of E2F recognition sites as positive or negative elements in regulation of the DNA polymerase [alpha] 180 kDa catalytic subunit gene promoter during Drosophila development Masamitsu Yamaguchi*, Yuko Hayashi, Fumiko Hirose, Yoshio Nishimoto and Akio Matsukage

Laboratory of Cell Biology, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya 464, Japan

Received June 27, 1997; Revised and Accepted August 12, 1997

ABSTRACT

The transcription factor E2F plays a key role in transcriptional control during the growth cycle of higher eukaryotic cells. The promoter region of the Drosophila DNA polymerase [alpha] 180 kDa catalytic subunit gene contains three E2F recognition sequences located at positions -353 to -342 (E2F site 1), -21 to -14 (E2F site 2) and -12 to -5 (E2F site 3) with respect to the transcription initiation site. Various base substitutions were generated in each or all of the three E2F sites in vitro to allow examination of their effects on E2F binding and promoter function in cultured Kc cells as well as in living flies. Glutathione S-transferase (GST)-E2F and GST-DP fusion proteins were found to cooperate in binding to the three E2F sites in the DNA polymerase [alpha] gene promoter in vitro. In contrast, an E2F-specific activity detected in nuclear extracts of Kc cells showed little affinity for E2F site 1 but strong binding to sites 2 and 3. Transient expression of Drosophila E2F in Kc cells activated the DNA polymerase [alpha] gene promoter and the target sites for activation coincided with E2F sites 2 and 3. However, analyses with transgenic flies indicate that E2F site 3 functions positively in terms of DNA polymerase [alpha] gene promoter activity, while E2F sites 1 and 2 rather have a negative control function. Thus E2F sites play distinct roles as positive or negative elements in regulation of the DNA polymerase [alpha] gene promoter during Drosophila development.

INTRODUCTION

Regulation of cell proliferation is essential for accurate generation of body structures in multicellular organisms. Switching between the non-proliferation and proliferation states of cells is closely associated with a coordinated shift in transcription of proliferation-related genes. DNA replication is clearly of prime importance for this process and there is much evidence that expression of the involved genes is finely regulated in accordance with progression of differentiation during development (1 ,2 ).

In budding yeast genes involved in DNA replication contain a common promoter element (MluI cell cycle box, 5'-ACGCGT) (3 ) and the specific transcription factor complex DSC1 (MBF) is required for expression at the G1/S boundary (4 ,5 ).

In mammalian cells expression of genes involved in DNA replication increases dramatically at late G1 in response to growth stimulation (6 ,7 ). Those encoding DNA polymerase [alpha], thymidine kinase, ribonucleotide reductase, dihydrofolate reductase (DHFR) and proliferating cell nuclear antigen (PCNA) contain at least one transcription factor E2F binding site (5'-TTTCGCGC) within their promoter regions (8 -10 ) or the first intron (11 ). Mammalian E2F is a heterogeneous factor representing the combined activity of at least seven gene products, called E2F-1, E2F-2, E2F-3, E2F-4, E2F-5, DP-1 and DP-2. The E2F and DP subtypes associate to form stable complexes and activate transcription in a cooperative manner (12 ,13 ). Regulation of E2F function also appears to play an important role during muscle terminal differentiation (14 ).

In Drosophila promoter regions of genes for the DNA polymerase [alpha] 180 kDa catalytic subunit (15 ), the 73 kDa regulatory subunit (16 ) and PCNA (17 ) contain a common 8 bp palindromic sequence (5'-TATCGATA), named the DNA replication-related element (DRE) (18 ). We have also found a specific DRE binding factor (DREF) consisting of an 80 kDa polypeptide homodimer (18 ) and cloned its cDNA (19 ). The DRE-DREF system appears to play a key role in differentiation-coupled repression of cell proliferation during Drosophila embryogenesis (20 ). cDNAs for Drosophila homologs of E2F-1 and DP-1 have been cloned (21 -23 ), these two proteins interacting with each other to effect sequence-specific DNA binding and optimal transactivation (22 ). Multiple E2F recognition sequences have been identified in the promoters of the Drosophila DNA polymerase [alpha] (21 ) and PCNA genes (24 ) and transcription of these genes is completely lost in E2F mutant embryos after division cycle 16 (25 ). We have reported that E2F recognition sites are essential for PCNA gene promoter activity in vivo (24 ). However, in the case of the DNA polymerase [alpha] gene the precise role(s) of each E2F recognition sequence for promoter activity in vivo has yet to be determined.

In the present study we therefore generated mutations in each or all of the three E2F sites in the DNA polymerase [alpha] gene promoter and subsequently examined their effects on E2F binding and promoter function in cultured Kc cells as well as in living flies. Although we detected a binding factor(s) for E2F sites 2 and 3, its binding specificity was found to be different from that of recombinant Drosophila E2F and DP. Transient expression of Drosophila E2F in Kc cells activated the DNA polymerase [alpha] gene promoter and the target site for activation coincided with E2F recognition sites 2 and 3. However, analyses with transgenic flies indicated that whereas E2F site 3 functions positively to stimulate DNA polymerase [alpha] gene promoter activity, sites 1 and 2 rather have a negative control function throughout Drosophila development.

MATERIALS AND METHODS

Oligonucleotides

The sequences of double-stranded oligonucleotides containing E2F recognition sites in the Drosophila DNA polymerase [alpha] gene promoter were as follows:
Pol[alpha]site1attggtaccTCGGATTTCCCGCCAAAATAT
        ggAGCCTAAAGGGCGGTTTTATA
Pol[alpha]site2+3gatcCGATATGTTCCCGCCATTCCCGCTTTGA
        GCTATACAAGGGCGGTAAGGGCGAAACTctag
Pol[alpha]mut2gatcCGATATGggCaaGCCATTCCCGCTTTGA
        GCTATACccGttCGGTAAGGGCGAAACTctag
Pol[alpha]mut3gatcCGATATGTTCCCGCCAggCaaGCTTTGA
        GCTATACAAGGGCGGTccGttCGAAACTctag
Pol[alpha]mut2+3gatcCGATATGggCaaGCCAggCaaGCTTTGA
        GCTATACccGttCGGTccGttCGAAACTctag
The sequences of double-stranded oligonucleotides containing two E2F sites or their base substituted derivatives in the adenovirus E2 gene promoter (26 ) were as follows:
AdE2FwtgatccTCCGTTTTCGCGCTTAAATTTGAGAAAGGGCGCGAAACTGGa
        gAGGCAAAAGCGCGAATTTAAACTCTTTCCCGCGCTTTGACCtctag
AdE2FmutgatccTCCGTTgTCGaGCTTAAATTTGAGAAAGGGCtCGAcACTGGa
        gAGGCAAcAGCtCGAATTTAAACTCTTTCCCGaGCTgTGACCtctag

Substituted nucleotides are shown by small letters and the E2F recognition sequences are underlined. The double-stranded 30 bp oligonucleotide DRE-P contains the 24 bp DRE sequence of the PCNA gene promoter and the 6 bp linker sequence (18 ) and DRE-PM contains a 2 bp substitution in the DRE (18 ). The other oligonucleotides used were:
Pol[alpha]KpnIwt5'-ATTGGTACCTCGGATTTCCCGCCAAAATAT;
Pol[alpha]KpnImut5'-ATTGGTACCTCGGATGGCAATACCCAATATAGCAGTCATTTT;
Pol[alpha]SacIIwt5'-GTGCCGCGGGATGGAGGATGATCAAAGCGG;
Pol[alpha]SacIImut2

5'-GTGCGCGGGATGGAGGATGATCAAAGCGGGAATGGCTTG
CCCATATCGATAACAGAGC;
Pol[alpha]SacIImut3

5'-GTGCCGCGGGATGGAGGATGATCAAAGCTTGCCTGGCGGGA
ACATATCGATAACAGAGC;
Pol[alpha]SacIImut2+3

5'-GTGCCGCGGGATGGAGGATGATCAAAGCTTGCCTGGCTTG
CCCATATCGATAACAGAGC.

Plasmid constructs

The plasmid pDgpol[alpha]2.4BB contains a 2.4 kb BamHI fragment of the DNA polymerase [alpha] gene (15 ). A DNA polymerase [alpha] gene fragment from -358 to +15 was generated by the PCR method (27 ) using pDgpol[alpha]2.4BB as template with Pol[alpha]KpnIwt and Pol[alpha]SacIIwt as primers. The PCR product was digested with KpnI and SacII, then inserted between KpnI and SacII sites of plasmid pSKCAT (28 ) to create plasmid p5'-358Dpol[alpha]CAT. Plasmid p5'-358Dpol[alpha]mut1CAT was constructed in the same way except that Pol[alpha]KpnImut and Pol[alpha]SacIIwt were used as PCR primers. Plasmids p5'-358Dpol[alpha]mut2CAT, p5'-358Dpol[alpha]mut3CAT and p5'-358Dpol[alpha]mut2+3CAT were constructed in the same way except that Pol[alpha]SacIImut2, Pol[alpha]SacIImut3 and Pol[alpha]SacIImut2+3 in addition to Pol[alpha]KpnIwt were used as PCR primers. Plasmid p5'-358Dpol[alpha]mut1+2+3CAT was constructed in the same way except that Pol[alpha]KpnImut and Pol[alpha]SacIImut2+3 were used as PCR primers. The obtained plasmids were verified by nucleotide sequence analysis with synthetic primers (29 ).

To construct plasmid p5'-358Dpol[alpha]lacZW8HS, p5'-358Dpol[alpha]CAT was digested with KpnI (-358), blunt-ended using T4 DNA polymerase and then digested with SacII (+15). A 373 bp fragment was isolated and inserted between the blunt-ended XhoI (-607) and SacII (+23) sites of p5'-607DPCNAlacZW8HS. Plasmid p5'-607DPCNAlacZW8HS (28 ) contains the PCNA gene fragment spanning -607 to +137 fused with lacZ in a P element vector. To create mutated derivatives, fragments having various mutations in E2F sites were isolated from CAT plasmids in the same way, then inserted between the blunt-ended XhoI (-607) and SacII (+23) sites of p5'-607DPCNAlacZW8HS. The plasmids obtained were verified by nucleotide sequence analysis with synthetic primers.

The expression plasmids Act-dE2F (22 ) and Act-dDP (22 ) respectively contain Drosophila E2F and DP full-length cDNAs placed under control of the Drosophila actin 5C gene promoter (30 ). Expression plasmid pdrosE2F1WT (21 ) contains Drosophila E2F cDNA covering amino acids 77 to the C-terminal end of the E2F protein fused with an N-terminal 11 amino acid region of the Ubx gene. This plasmid is also under control of the Drosophila actin 5C gene promoter. Plasmid pDhsp70-L (31 ) contains the luciferase gene under control of the Drosophila hsp70 gene promoter (32 ).

Fusion genes of E2F with glutathione S-transferase (GST) and of DP with GST were prepared as described earlier (24 ) to produce full-length E2F and DP proteins fused with GST.

All plasmids were propagated in Escherichia coli XL-1 Blue, isolated by standard procedures (33 ) and further purified through two cycles of ethidium bromide/CsCl density gradient centrifugation.

Preparation of nuclear extracts and band mobility shift assay

Preparation of nuclear extracts from Kc cells was as described elsewhere (18 ). 32P-end-labeled Pol[alpha]site2+3 oligonucleotides (160 pg) and unlabeled competitor DNA fragments were incubated in 15 [mu]l reaction mixture containing 20 mM HEPES, pH 7.6, 150 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 12% glycerol, 0.5 [mu]g poly(dI[middot]dC) for 5 min on ice. Then nuclear extracts were added and the mixtures incubated for 15 min on ice. Complexes of DNA and binding protein(s) were electrophoretically separated from free probes in 4% polyacrylamide gels in 50 mM Tris-borate, pH 8.3, and 1 mM EDTA containing 2.5% glycerol at room temperature. Gels were then dried and autoradiographed.

Expression of GST fusion proteins and band mobility shift assay

Expression of GST-E2F and GST-DP fusion proteins was carried out as described elsewhere (34 ). Lysates of cells were prepared by sonication in buffer D containing 0.6 M KCl, 1 mM PMSF, 0.5% Triton X-100 and 1 [mu]g/ml each pepstatin, leupeptin and aprotinin, cleared by centrifugation at 12 000 g for 20 min at 4oC and used for band mobility shift assays using a 32P-end-labeled AdE2Fwt oligonucleotide (117 pg) as probe. The assay was carried out as described above except that the reaction mixture for binding contained 20 mM HEPES, pH 7.5, 120 mM KCl, 10 mM MgCl2, 1 mM EGTA, 0.5 mM dithiothreitol, 10% glycerol, 1 [mu]g sonicated salmon sperm DNA.

DNA transfection into cells, CAT assay and luciferase assay

Drosophila Kc cells (35 ) were grown in M3(BF) medium supplemented with 2% fetal calf serum (36 ) and plated at ~5 * 106 cells/60 mm dish for 16 h before DNA transfection by the calcium phosphate co-precipitation technique as described elsewhere (24 ). Aliquots of 1 or 0.5 [mu]g DNA polymerase [alpha] gene promoter-CAT plasmid as a reporter plasmid and 0.1 [mu]g pDhsp70-L as an internal control plasmid were co-transfected with the indicated amounts of effector plasmid. The total amount of effector plasmid was kept constant by addition of expression vector pAcGEM3 (28 ) and the total amount of DNA was adjusted to 10 [mu]g by addition of pGEM3. Cells were harvested at 48 h after transfection. Cell extracts were prepared and CAT activity was measured as described previously (37 ). The radioactivity of acetylated chloramphenicol on thin layer plates was quantified with an imaging analyzer BAS2000 (Fuji Film).

The luciferase assay was carried out by means of a PicaGene assay kit (Toyo Ink) as described previously (9 ). All assays were performed within the range of linear relation of activity to incubation time and protein amount. CAT activity was normalized to luciferase activity. The obtained values were essentially similar to those normalized to protein amount determined by BioRad protein assay.

Establishment of transgenic flies

Fly stocks were maintained at 25oC on standard food. Canton S flies were used as the wild-type strain. P element-mediated germline transformation was carried out as described earlier (38 ) and G1 transformants were selected on the basis of white eye color rescue (39 ). Multiple independent lines were obtained for each of the various fusion genes. The established transgenic fly strains and their chromosomal linkages are listed in Table 1 .

Analysis of expression patterns of DNA polymerase [alpha]-lacZ fusion genes

Quantitative measurement of [beta]-galactosidase activity in extracts was performed (40 ). Male transgenic flies were crossed with female wild-type flies. Groups of 50-100 dechorionated embryos, larvae, pupae and adult flies were homogenized in 500 [mu]l ice-cold [beta]-galactosidase assay buffer (50 mM potassium phosphate, pH 7.5, 1 mM MgCl2). Homogenates were centrifuged at 10 000 g at 4oC for 5 min. For each assay 50-200 [mu]l supernatant were added to give 1 ml assay buffer containing 1 mM chlorophenol red [beta]-D-galactopyranoside substrate (CPRG; Boehringer Mannheim). Reaction incubations were at 37oC in the dark. Substrate conversion was measured at 574 nm using a spectrophotometer 0.25, 0.5, 0.75, 1 and 1.5 h after addition of extract and the rate of color development was linear. [beta]-Galactosidase specific activity was defined as absorbance units/h/mg protein. To correct for endogenous [beta]-galactosidase activity extracts from the wild-type strain were included in each experiment and this background reading was subtracted from readings obtained with each transformant line. The protein concentrations of the extracts were determined by BioRad protein assay.

Table 1 . Transformants carrying lacZ fused to the DNA polymerase [alpha] gene 5'-flanking sequence
P element plasmidsStrainsChromosome linkage
p5'-358Dpol[alpha]lacZW8HS 1III
  20II
  27II
  44II
  57X
  61III
  76II
  93II
 100X
 101III
 103aX
p5'-358Dpol[alpha]mut1lacZW8HS 6III
  18II
  20II
  23II
  40X
p5'-358Dpol[alpha]mut2lacZW8HS 3III
  23II
p5'-358Dpol[alpha]mut3lacZW8HS 31II
  37III
  52II
  59II
  84II
p5'-358Dpol[alpha]mut2+3lacZW8HS 12III
  26III
  28aIII
  34II
  97X
p5'-358Dpol[alpha]mut1+2+3lacZW8HS 63III
  64III
  83II
  85II
 127II
aLines whose lacZ expression patterns are different from those of other lines carrying the same fusion gene.

RESULTS

GST-E2F and GST-DP fusion proteins cooperate to bind to the E2F recognition sequences in the DNA polymerase [alpha] gene promoter


Figure 1. Structure of the 5'-upstream region of the Drosophila DNA polymerase [alpha] gene and base substitution mutants in E2F recognition sites. The vertical lines with horizontal arrows indicate the transcription initiation site. The open and solid boxes indicate the 5'-untranslated and coding sequences of the DNA polymerase [alpha] gene respectively. The dark stippled boxes indicate the DRE sequences and the open circles indicate the E2F recognition sequences. A construct of the wild-type DNA polymerase [alpha]-CAT (p5'-358Dpol[alpha]CAT) fusion gene is also shown. Nucleotide sequences of E2F sites 1-3 are indicated in boxes. Site 1 contains an overlapping pair of E2F recognition sequences. Locations of each site relative to the transcription initiation site are indicated by numbers. Nucleotides substituted for the wild-type sequence are shown in each mutant.Three E2F sites have been identified in the promoter of the Drosophila DNA polymerase [alpha] gene (Fig. 1 ; 21 ). Site 1 has been demonstrated to be most effective for binding Drosophila E2F in Schneider cell nuclear extract (21 ). We therefore examined direct binding of E2F and DP to the three E2F sites.

Lysates were prepared from bacteria carrying pGST-E2F or pGST-DP and band mobility shift assays were carried out. As shown in Figure 2 A, a DNA-protein complex was only detected with the chemically synthesized AdE2Fwt oligonucleotide containing the two E2F recognition sequences of the adenovirus E2 gene promoter (26 ) when both GST-E2F and GST-DP lysates were mixed. Specificity of binding was evident in competition with wild-type and mutant E2F sites from the adenovirus E2 gene promoter (Fig. 2 B, lanes a-f and r-v). Pol[alpha]site1 oligonucleotide (Fig. 1 ) containing an overlapping pair of E2F recognition sequences of the DNA polymerase [alpha] promoter effectively competed for binding (Fig. 2 B, lanes l-q). Pol[alpha]site2+3 oligonucleotide (Fig. 1 ) containing two E2F recognition sequences competed for binding (Fig. 2 B, lanes g-k), although less effectively than the Pol[alpha]site1 oligonucleotide. When each or both of these two E2F recognition sequences were mutated by base substitutions (Fig. 1 ) and added to the binding reaction as competitor, the oligonucleotide pol[alpha]mut3 carrying base substitutions in the E2F site 3 competed for binding less effectively than wild-type pol[alpha]site2+3 (Fig. 2 C, lanes l-q). Oligonucleotides pol[alpha]mut2 and pol[alpha]mut2+3 did not compete at all (Fig. 2 C, lanes g-k and r-v). Thus the E2F recognition sequences of the DNA polymerase [alpha] gene promoter have high affinity for the complex of GST-E2F and GST-DP fusion proteins and both site 1 and site 2 appear to play major roles in binding.


Figure 2. Cooperative binding of GST-E2F and GST-DP to the oligonucleotide AdE2Fwt and competition by wild-type and mutant E2F site oligonucleotides. (A) Radiolabeled double-stranded AdE2Fwt oligonucleotides were incubated with the indicated amounts of lysates from bacteria carrying pGEX-2T (lanes a-c), pGST-dE2F (lanes b and d) or pGST-dDP (lanes c and d), individually (lane a) or in combination (lanes b-d). (B) Radiolabeled double-stranded AdE2Fwt oligonucleotides were incubated with 1 [mu]l each of lysates from bacteria carrying pGST-dE2F or pGST-dDP in the presence of the indicated amounts of competitor oligonucleotides (indicated at the top of each lane). AdE2Fwt, oligonucleotides containing two wild-type E2F sites from the adenovirus E2 gene promoter; AdE2Fmut, oligonucleotides containing two mutant E2F sites from the adenovirus E2 gene promoter; pol[alpha]site2+3, oligonucleotides containing wild-type E2F sites 2 and 3 from the DNA polymerase [alpha] gene promoter; pol[alpha]site1, oligonucleotides containing wild-type E2F site 1 from the DNA polymerase [alpha] gene promoter. (C) Radiolabeled double-stranded AdE2Fwt oligonucleotides were incubated with 1 [mu]l each of lysates from bacteria carrying pGST-dE2F or pGST-dDP in the presence of the indicated amounts of competitor oligonucleotides. pol[alpha]site2+3, oligonucleotides containing wild-type E2F sites 2 and 3 from the DNA polymerase [alpha] gene promoter; pol[alpha]mut2, oligonucleotides having a mutation in E2F site 2 of pol[alpha]site2+3; pol[alpha]mut3, oligonucleotides having a mutation in E2F site 3 of pol[alpha]site2+3; pol[alpha]mut2+3, oligonucleotides having mutations in both E2F sites 2 and 3 of pol[alpha]site2+3.

Detection of a binding factor(s) in Drosophila Kc cell nuclear extracts that discriminates between the E2F sites

Nuclear extracts were prepared from Kc cells and band mobility shift assays were carried out. As shown in Figure 3 A, lane a, a DNA-protein complex could be detected using oligonucleotide pol[alpha]site2+3 as probe. The band shifted with 32P-labeled pol[alpha]site2+3 was diminished by adding an excess amount of unlabelled pol[alpha]site2+3 as competitor (Fig. 3 A, lanes b-d). The oligonucleotide containing the wild-type E2F site from the adenovirus E2 promoter (26 ) competed for binding when added to the reaction in excess (Fig. 3 A, lanes h-j), but this was not the case with the mutant E2F site from the adenovirus E2 promoter (Fig. 3 A, lanes k-m). Unexpectedly, oligonucleotide pol[alpha]site1 did not compete for binding under the examined conditions (Fig. 3 A, lanes e and f) and no formation of the sequence-specific DNA-protein complex was observed using a pol[alpha]site1 oligonucleotide as probe (data not shown). As shown in Figure 3 B, the oligonucleotides carrying base substitutions in either or both of E2F sites 2 and 3 did not compete for binding, so that both appear to be required.


Figure 3. Complex formation between pol[alpha]site2+3 oligonucleotides and Kc cell nuclear extracts and competition by various E2F recognition sequences. Radiolabeled double-stranded pol[alpha]site2+3 oligonucleotides were incubated with Kc cell nuclear extract (2 [mu]g protein) in the presence or absence (0) of the indicated amounts of competitor oligonucleotides (indicated at the top of each lane). (A) pol[alpha]site2+3, oligonucleotides containing E2F sites 2 and 3 from the DNA polymerase [alpha] gene promoter; pol[alpha]site1, oligonucleotides containing E2F site 1 from the DNA polymerase [alpha] gene promoter; AdE2Fwt, oligonucleotides containing two wild-type E2F sites from the adenovirus E2 gene promoter; AdE2Fmut, oligonucleotides containing two mutant E2F sites from the adenovirus E2 gene promoter. (B) pol[alpha]site2+3, oligonucleotides containing wild-type E2F sites 2 and 3 from the DNA polymerase [alpha] gene promoter; pol[alpha]mut2, oligonucleotides having a mutation in E2F site 2 of pol[alpha]site2+3; pol[alpha]mut3, oligonucleotides having a mutation in E2F site 3 of pol[alpha]site2+3; pol[alpha]mut2+3, oligonucleotides having mutations in both E2F sites 2 and 3 of pol[alpha]site2+3.

Effects of mutations in the E2F recognition sequences on the DNA polymerase [alpha] gene promoter activity in cultured Kc cells

The DNA polymerase [alpha] gene promoter carrying mutations in either or both of two E2F recognition sequences was placed upstream of the CAT gene in a CAT vector (Fig. 1 ). Plasmids carrying these constructs were transfected into Kc cells and CAT expression levels determined. As shown in Figure 4 , the plasmid carrying base substitutions in E2F site 1 showed only a marginal reduction of CAT expression as compared with that of the original plasmid, p5'-358Dpol[alpha]CAT. The plasmid carrying base substitutions in E2F site 3 showed 66% of the CAT expression of p5'-358Dpol[alpha]CAT (Fig. 4 , lanes g and h). More extensive reduction of CAT expression was observed with plasmid p5'-358Dpol[alpha]mut2CAT carrying base substitutions in E2F site 2 (Fig. 4 , lanes e and f). A slight further reduction in CAT expression was observed with plasmid p5'-358Dpol[alpha]mut1+2+3CAT carrying base substitutions in all E2F sites (Fig. 4 , lanes k and l). These results indicate that E2F site 2 plays a major role and sites 1 and 3 might play additional roles in regulation of DNA polymerase [alpha] gene promoter activity.


Figure 4. Effects of mutations in E2F recognition sites on DNA polymerase [alpha] gene promoter activity in Kc cells. One microgram each of CAT plasmids harboring wild-type or mutant DNA polymerase [alpha] promoters (indicated at the top of each lane) were co-transfected with 0.1 [mu]g pDhsp70-L plasmid into Kc cells. Forty eight hours after transfection cell extracts were prepared to determine CAT expression levels, normalized to luciferase activity. Averaged values obtained from two independent dishes with standard deviations are given as CAT activity relative to that of p5'-358Dpol[alpha]CAT (lanes a and b). Promoterless CAT (pSKCAT) plasmids were included as controls (lanes m and n). Acetylated and non-acetylated forms of [14C]chloramphenicol are marked by Ac and CM respectively.

Mapping of the target region in the DNA polymerase [alpha] gene promoter for activation by E2F protein


Figure 5. Effect of co-transfecting E2F or DP expression plasmid on CAT activity directed by the regulatory region of the DNA polymerase [alpha] gene. Aliquots of 0.5 [mu]g plasmid p5'-358Dpol[alpha]CAT were co-transfected into Kc cells with 0.1 [mu]g pDhsp70-L plasmid and the indicated amounts of Act-dE2F (open circles), pdrosE2F1WT (solid circles) or Act-dDP (solid squares). Forty eight hours after transfection cell extracts were prepared to determine CAT expression levels, normalized to luciferase activity and plotted against activity in the absence of effector plasmid. Averaged values obtained from three independent transfections are shown.

Activation of DNA polymerase [alpha] gene promoter-directed CAT expression by E2F in Drosophila Schneider cells has been reported (21 ), although the target region in the promoter responsible for activation has not been determined. To confirm this observation, a co-transfection assay using cultured Drosophila Kc cells was carried out. Plasmid p5'-358Dpol[alpha]CAT was used as the reporter plasmid. Expression plasmids for Drosophila E2F, Act-dE2F (22 ) and pdrosE2F1WT (21 ), and for Drosophila DP, Act-dDP (22 ), were used as effector plasmids. Expression of the E2F protein activated DNA polymerase [alpha] promoter-directed CAT expression 2- to 3-fold (Fig. 5 ). However, expression of DP protein was without effect (Fig. 5 ). In addition, when the DP-expressing plasmid was co-transfected with the reporter plasmid and the E2F-expressing plasmid, no further activation of CAT expression was observed (data not shown). These results indicate that E2F protein can activate the DNA polymerase [alpha] gene promoter and the level of E2F protein but not that of DP protein appears to be rate limiting for activation.

To examine the roles of the various E2F recognition sites in activation by E2F, base substitution derivatives of p5'-358Dpol[alpha]- CAT were co-transfected with the E2F-expressing plasmid. As shown in Figure 6 A, the E2F-expressing plasmid still activated CAT expression from plasmid p5'-358Dpol[alpha]mut1CAT. However, base substitutions in both E2F sites 2 and 3 as well as those in all three sites completely abolished the response to E2F expression (Fig. 6 A, lanes i-p). In order to determine the separate importance of each of E2F sites 2 and 3, p5'-358Dpol[alpha]mut2CAT and p5'-358Dpol[alpha]mut3CAT were co-transfected with the E2F- expressing plasmid. As shown in Figure 6 B, activated CAT expression was still observed with both. Therefore, at least one of these two E2F sites is required for E2F protein to activate the DNA polymerase [alpha] gene promoter.


Figure 6. Mapping of the target region in the DNA polymerase [alpha] gene for activation by E2F protein in Kc cells. Aliquots of 0.5 [mu]g of each of the indicated base substitution derivatives of plasmid p5'-358Dpol[alpha]CAT were co-transfected into Kc cells with (+) or without (-) 1 [mu]g Act-dE2F plasmid. An aliquot of 0.1 [mu]g pDhsp70-L plasmid was also included to normalize CAT activity to the luciferase activity. Forty eight hours after transfection cell extracts were prepared to determine CAT expression levels. Averaged values obtained from two independent dishes are given as fold stimulation relative to those obtained by transfections without Act-dE2F effector plasmid. (A) and (B) show independent experiments, with wild-type p5'-358Dpol[alpha]CAT included as a control. Acetylated and non-acetylated forms of [14C]chloramphenicol are marked Ac and CM respectively.

Roles of E2F recognition sites in function of the DNA polymerase [alpha] gene promoter during fly development

Although the results of CAT transient expression assay in Kc cells clearly demonstrated an important role for E2F recognition sites in DNA polymerase [alpha] promoter activity, these observations have to be confirmed in living flies and transgenic Drosophila provide an appropriate system to characterize transcriptional regulatory elements in vivo. We have established transgenic flies carrying DNA polymerase [alpha] (-358 to +15) and lacZ fusion genes. Established transgenic lines and their chromosomal linkages are listed in Table 1 . Male transgenic flies were crossed with wild-type females to examine zygotic lacZ expression. This was found to be high in embryos, first and second instar larvae and adult females and low at other stages of development (Fig. 7 , top). This pattern of expression is very similar to the levels of zygotically expressed DNA polymerase [alpha] mRNA during development (15 ).


Figure 7. Effects of base substitution mutations in E2F recognition sites on DNA polymerase [alpha] gene promoter activity in transgenic flies. Male transgenic flies (indicated in each panel) were crossed with female wild-type flies and extracts were prepared from Drosophila bodies at various stages of development. The [beta]-galactosidase-specific activities in the extracts are expressed as absorbance units/h/mg protein. Closed bars indicate the average values for independent transgenic strains carrying the indicated fusion gene. Deviations among independent strains are also indicated. Numbers (n) of independent strains carrying the same fusion gene are given in each panel.

To examine the role of E2F recognition sites in DNA polymerase [alpha] gene promoter activity during Drosophila development, we generated DNA polymerase [alpha]-lacZ fusion genes carrying base substitutions in either or various combinations of three E2F recognition sites. These fusion genes were then introduced into flies by germline transformation as listed in Table 1 . Activities of the modified promoters were then monitored by the quantitative [beta]-galactosidase assay at various developmental stages of Drosophila. As shown in Figure 7 , mutation in either E2F site 1 or site 2 resulted in rather higher expression of lacZ than in the wild-type construct throughout development. Mutation in E2F site 3 almost completely abolished lacZ expression in embryos, suggesting that this site is essential for stimulation of promoter activity during embryogenesis. Reduced expression of lacZ was also observed in larvae having a mutation in E2F site 3. However, high expression of lacZ in adult females was still observed. Flies having mutations in both E2F site 2 and site 3 showed a similar lacZ expression pattern as those having only the mutation in E2F site 3. Even when all three E2F sites were mutated, lacZ expression in larvae, pupae and in both male and female adults was observed. These results indicate that E2F site 3 functions positively in DNA polymerase [alpha] gene promoter activity, while E2F sites 1 and 2 rather have a negative control function.

DISCUSSION

Three E2F recognition sites have been identified in the gene for the 180 kDa catalytic subunit of Drosophila DNA polymerase [alpha] (21 ). Generation of various base substitutions singly or in combination of the recognition sequences in vitro allowed examination of their effects on E2F binding and promoter function in cultured Kc cells as well as in transgenic flies. As summarized in Table 2 , we have confirmed binding of complexes of GST-E2F and GST-DP fusion proteins to all three E2F sites, with sites 1 and 2 appearing to be more effective for binding than site 3. A binding factor(s) for E2F sites 2 and 3 was detected in nuclear extracts of Drosophila Kc cells. Although the factor(s) required both E2F sites 2 and 3 for binding, it showed little affinity for E2F site 1 and no detection of binding activity to E2F site 1 in nuclear extracts has so far been possible. One possibility to interpret this difference is that the GST tag might modify the DNA binding properties of the E2F-DP complex. Another possibility is that complexes of E2F and DP in nuclear extracts are likely to be associated with other protein(s), like RBF (RB family protein) (23 ,41 ), and therefore might behave differently from complexes of GST-E2F and GST-DP fusion proteins. Further analyses using specific antibodies to E2F, DP and RBF might make it possible to identify each component in the complexes formed in nuclear extracts.

Table 2 . Summary of the roles of E2F recognition sites of the DNA polymerase [alpha] gene
 E2F sites
 123
Binding activity
  GST-E2F/GST-DP++++++
  Kc cell nuclear extract-++
Promoter stimulation
  Kc cell[up arrow][up arrow][up arrow][up arrow][up arrow][up arrow]
  Embryo <=> <=> <=> <=> [up arrow][up arrow][up arrow]
  Larva <=> <=> <=> <=> [up arrow][up arrow]
  Ovary <=> <=> No
[up arrow], [up arrow][up arrow], [up arrow][up arrow][up arrow], weak moderate and strong stimulation; <=> , <=> <=> , weak and moderate repression.
No, no significant effect

A number of studies have been conducted to explore E2F effects during the cell cycle. In mammalian cells expression of a group of genes that are commonly regulated in late G1 of the growth response and that encode proteins important for DNA replication appear to be regulated by E2F (8 ). Thus critical roles of E2F sites for regulated expression in late G1 have been demonstrated with the genes for DHFR (10 ) and PCNA (11 ). However, such observations with cultured cell systems have to be confirmed in living organisms and in this sense transgenic Drosophila provide an appropriate system to characterize E2F recognition sites in vivo. In the present study of the DNA polymerase [alpha] gene promoter function we have observed several differences in results between in vitro and transgenic fly analyses (Table 2 ). It is known that high copy numbers (>105) of plasmid DNA are incorporated into cells by the calcium phosphate co-precipitation method and most of them exist in an episomal state in cells. In contrast, the P element method provides only one copy of the transgene integrated into the chromosome. Therefore, transgenic fly analysis is very likely to more faithfully represent regulation in vivo.

Previously we identified two E2F sites in the promoter region of the PCNA gene (24 ). Analyses with transgenic flies demonstrated that these two sites are essential for PCNA gene promoter activity throughout development (24 ). However, E2F sites alone proved to be insufficient for PCNA gene promoter activity during the embryonic and larval stages, since deletion of the upstream region containing the URE and DRE sequences completely abolished the associated promoter activity (42 ). Thus the URE, DRE and E2F sites presumably cooperate to direct optimal promoter activity of the PCNA gene.

In the case of the DNA polymerase [alpha] gene promoter two of the three E2F recognition sites were here found to act rather negatively on promoter activity during development with only the E2F site 3 stimulating promoter activity. E2F sites of several mammalian genes have been reported to act as negative elements in the G0 and G1 phases of the cell cycle, but release of RB protein from the binding complex effects a switch to a positive influence (43 ,44 ). Therefore, protein complexes interacting with E2F sites 1 and 2 in vivo might contain negative regulators, like RBF, and those interacting with E2F site 3 might not.

The observation that even when all E2F sites 1-3 were mutated lacZ expression in larvae, pupae and adults was still observed (Fig. 7 ) demonstrates that the requirement for DNA polymerase [alpha] gene promoter activity is less stringent than for the PCNA gene (24 ). Since the DNA polymerase [alpha] gene promoter contains three DRE sequences, while the PCNA gene promoter contains just one, they might be able to substitute at least partly the function of E2F sites during development. Alternatively, some unidentified additional E2F sites might play roles in activation of the DNA polymerase [alpha] gene promoter in vivo.

ACKNOWLEDGEMENTS

We are grateful to Drs K.Ohtani and J.Nevins for providing pdrosE2F1WT, N.Dyson for Act-dE2F and Act-dDP and M.Asano, J.Nevins and M.Moore for critical reading of the manuscript. This work was supported in part by grants-in-aid from the Ministry of Education, Science and Culture, Japan.

REFERENCES

1 Matsukage,A., Kitani,H., Yamaguchi,M., Kusakabe,M., Morita,T. and Koshida,Y. (1986) Dev. Biol., 117, 226-232. MEDLINE Abstract

2 Matsukage,A., Hirose,F. and Yamaguchi,M. (1994) Jpn J. Cancer Res., 85, 1-8. MEDLINE Abstract

3 Lowndes,N.F., Johnson,A.L. and Johnston,L.H. (1991) Nature, 350, 247-250. MEDLINE Abstract

4 Dirick,L., Moll,T., Auer,H. and Nasmyth,K. (1992) Nature, 357, 508-513. MEDLINE Abstract

5 Lowndes,N.F., Johnston,A.L., Breeden,L. and Johnston,L.H. (1992) Nature, 357, 505-508. MEDLINE Abstract

6 Baserga,R. (1991) J. Cell Sci., 98, 433-436. MEDLINE Abstract

7 Miyazawa,H., Izumi,M., Tada,S., Takada,R., Masutani,M., Ui,M. and Hanaoka,F. (1993) J. Biol. Chem., 268, 8111-8122. MEDLINE Abstract

8 Nevins,J.R. (1992) Science, 258, 424-429. MEDLINE Abstract

9 Yamaguchi,M., Hayashi,Y., Matsuoka,S., Takahashi,T. and Matsukage,A. (1994) Eur. J. Biochem., 221, 227-237. MEDLINE Abstract

10 Slansky,J.E., Li,Y., Kaelin,W.G. and Farnham,P.J. (1993) Mol. Cell. Biol., 13, 1610-1618. MEDLINE Abstract

11 Lee,H.-H., Chiang,W.-H., Chiang,S.-H., Liu,Y.-C., Hwang,J. and Ng,S.-Y. (1995) Gene Expression, 4, 95-109. MEDLINE Abstract

12 Bandara,L.R., Buck,V.M., Zamanian,M., Johnston,L.H. and La Thangue,N.B. (1993) EMBO J., 12, 4317-4324. MEDLINE Abstract

13 Helin,K., Wu,C., Fattaey,A., Lees,J., Dynlacht,B., Ngwu,C. and Harlow,E. (1993) Genes Dev., 7, 1850-1861. MEDLINE Abstract

14 Shin,E.K., Shin,A., Paulding,C., Schaffhausen,B. and Yee,A.S. (1995) Mol. Cell. Biol., 15, 2252-2262. MEDLINE Abstract

15 Hirose,F., Yamaguchi,M., Nishida,Y., Masutani,M., Miyazawa,H., Hanaoka,F. and Matsukage,A. (1991) Nucleic Acids Res., 19, 4991-4998. MEDLINE Abstract

16 Takahashi,Y., Yamaguchi,M., Hirose,F., Cotterill,S., Kobayashi,J., Miyajima,S. and Matsukage,A. (1996) J. Biol. Chem., 271, 14541-14547. MEDLINE Abstract

17 Yamaguchi,M., Nishida,Y., Moriuchi,T., Hirose,F., Hui,C.-C., Suzuki,Y. and Matsukage,A. (1990) Mol. Cell. Biol., 10, 872-879. MEDLINE Abstract

18 Hirose,F., Yamaguchi,M., Handa,H., Inomata,Y. and Matsukage,A. (1993) J. Biol. Chem., 268, 2092-2099. MEDLINE Abstract

19 Hirose,F., Yamaguchi,M., Kuroda,K., Omori,A., Hachiya,T., Ikeda,M., Nishimoto,Y. and Matsukage,A. (1996) J. Biol. Chem., 271, 3930-3937. MEDLINE Abstract

20 Hirose,F., Yamaguchi,M. and Matsukage,A. (1994) J. Biol. Chem., 269, 2937-2942. MEDLINE Abstract

21 Ohtani,K. and Nevins,J.R. (1994) Mol. Cell. Biol., 14, 1603-1612. MEDLINE Abstract

22 Dynlacht,B.D., Brook,A., Dembski,M., Yenush,L. and Dyson,N. (1994) Proc. Natl. Acad. Sci. USA, 91, 6359-6363. MEDLINE Abstract

23 Hao,X.F., Alphey,L., Bandara,L.R., Lam,E.W.-F., Glover,D. and La Thangue,N.B. (1995) J. Cell Sci., 108, 2945-2954. MEDLINE Abstract

24 Yamaguchi,M., Hayashi,Y. and Matsukage,A. (1995) J. Biol. Chem., 270, 25159-25165. MEDLINE Abstract

25 Duronio,R.J., O'Farrell,P.H., Xie,J.E., Brook,A. and Dyson,N. (1995) Genes Dev., 9, 1445-1455. MEDLINE Abstract

26 Yee,A.S., Raychaudhuri,P., Jakoi,L. and Nevins,J.R. (1989) Mol. Cell. Biol., 9, 578-585. MEDLINE Abstract

27 Kawasaki,E.S. (1990) In Innis,M.A., Gelfand,D.H., Sninsky,J.J. and White,T.J. (eds), PCR Protocols: A Guide to Methods and Applications. Academic Press, San Diego, CA, pp. 21-27.

28 Yamaguchi,M., Hirose,F.,Nishida,Y. and Matsukage,A. (1991) Mol. Cell. Biol., 11, 4909-4917. MEDLINE Abstract

29 Sanger,F., Nicklen,S. and Coulson,A.R. (1977) Proc. Natl. Acad. Sci. USA, 74, 5463-5467. MEDLINE Abstract

30 Bond-Matthews,B. and Davidson,N. (1988) Gene, 62, 289-300. MEDLINE Abstract

31 Yamaguchi,M., Hayashi,Y., Nishimoto,Y., Hirose,F. and Matsukage,A. (1995) J. Biol. Chem., 270, 15808-15814. MEDLINE Abstract

32 Karch,F., Torok,I. and Tissieres,A. (1981) J. Mol. Biol., 148, 219-230. MEDLINE Abstract

33 Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

34 Smith,D.B. and Johnson,K.S. (1988) Anal. Biochem., 67, 31-40.

35 Echalier,G. and Ohanessian,A. (1970) In Vitro, 6, 162-172. MEDLINE Abstract

36 Cross,D.P. and Sang,J.H. (1978) J. Embryol. Exp. Morphol., 45, 161-172. MEDLINE Abstract

37 Yamaguchi,M., Hayashi,Y. and Matsukage,A. (1988) Nucleic Acids Res., 16, 8773-8787. MEDLINE Abstract

38 Spradling,A.C. (1986) In Roberts,D.B. (ed.), Drosophila: A Practical Approach. IRL Press, Oxford, UK, pp. 175-197.

39 Robertson,H.M., Preston,C.R., Philips,R.W., Johnson-Schlitz,D.M., Benz,W.K. and Engels,W.R. (1988) Genetics, 118, 461-470. MEDLINE Abstract

40 Fridell,Y.-W.C. and Searles,L.L. (1992) Mol. Cell. Biol., 12, 4571-4577. MEDLINE Abstract

41 Du,W., Vidal,M., Xie,J.-E. and Dyson,N. (1996) Genes Dev., 10, 1206-1218. MEDLINE Abstract

42 Yamaguchi,M., Hirose,F. and Matsukage,A. (1996) Genes Cells, 1, 47-58. MEDLINE Abstract

43 Weinberg,R.A. (1996) Cell, 85, 457-459. MEDLINE Abstract

44 Weintraub,S.J., Prater,C.A. and Dean,D.C. (1992) Nature, 358, 259-261. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +81 52 762 6111 (ext. 8820); Fax: +81 52 763 5233; Email: myamaguc@aichi-cc.pref.aichi.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
K. Otsuki, Y. Hayashi, M. Kato, H. Yoshida, and M. Yamaguchi
Characterization of dRFX2, a novel RFX family protein in Drosophila
Nucleic Acids Res., October 19, 2004; 32(18): 5636 - 5648.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M.-S. Hwang, Y.-S. Kim, N.-H. Choi, J.-H. Park, E.-J. Oh, E.-J. Kwon, M. Yamaguchi, and M.-A. Yoo
The Caudal homeodomain protein activates Drosophila E2F gene expression
Nucleic Acids Res., December 1, 2002; 30(23): 5029 - 5035.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. V. Frolov, D. S. Huen, O. Stevaux, D. Dimova, K. Balczarek-Strang, M. Elsdon, and N. J. Dyson
Functional antagonism between E2F family members
Genes & Dev., August 15, 2001; 15(16): 2146 - 2160.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E.-J. Kwon, E.-J. Oh, Y.-S. Kim, F. Hirose, K. Ohno, Y. Nishida, A. Matsukage, M. Yamaguchi, and M.-A. Yoo
E2F-dependent transcription of the raf proto-oncogene during Drosophila development
Nucleic Acids Res., April 15, 2001; 29(8): 1808 - 1814.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. S. Nishikawa, M. Izumi, H. Uchida, M. Yokoi, H. Miyazawa, and F. Hanaoka
Cloning and characterization of the 5'-upstream sequence governing the cell cycle-dependent transcription of mouse DNA polymerase {alpha} 68 kDa subunit gene
Nucleic Acids Res., April 1, 2000; 28(7): 1525 - 1534.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
D. Myster, P. Bonnette, and R. Duronio
A role for the DP subunit of the E2F transcription factor in axis determination during Drosophila oogenesis
Development, January 8, 2000; 127(15): 3249 - 3261.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (319K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Matsukage, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Matsukage, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?